Annual EBIT
-$271.33 M
+$22.09 M+7.53%
December 31, 2023
Summary
- As of February 20, 2025, FGEN annual earnings before interest & taxes is -$271.33 million, with the most recent change of +$22.09 million (+7.53%) on December 31, 2023.
- During the last 3 years, FGEN annual EBIT has fallen by -$85.01 million (-45.62%).
- FGEN annual EBIT is now -6297.90% below its all-time high of -$4.24 million, reached on December 31, 2013.
Performance
FGEN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$12.98 M
-$2.06 M-18.84%
September 30, 2024
Summary
- As of February 20, 2025, FGEN quarterly earnings before interest & taxes is -$12.98 million, with the most recent change of -$2.06 million (-18.84%) on September 30, 2024.
- Over the past year, FGEN quarterly EBIT has increased by +$38.72 million (+74.90%).
- FGEN quarterly EBIT is now -111.10% below its all-time high of $116.94 million, reached on June 30, 2019.
Performance
FGEN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$104.09 M
+$46.21 M+30.75%
September 30, 2024
Summary
- As of February 20, 2025, FGEN TTM earnings before interest & taxes is -$104.09 million, with the most recent change of +$46.21 million (+30.75%) on September 30, 2024.
- Over the past year, FGEN TTM EBIT has increased by +$167.25 million (+61.64%).
- FGEN TTM EBIT is now -284.95% below its all-time high of $56.28 million, reached on June 30, 2019.
Performance
FGEN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FGEN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.5% | +74.9% | +61.6% |
| 3 y3 years | -45.6% | +74.9% | +61.6% |
| 5 y5 years | -261.2% | +74.9% | +61.6% |
FGEN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.5% | -18.8% | +90.4% | at high | +71.3% |
| 5 y | 5-year | -267.8% | +7.5% | -125.5% | +90.4% | -41.1% | +71.3% |
| alltime | all time | -6297.9% | +7.5% | -111.1% | +90.4% | -284.9% | +71.3% |
FibroGen EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.98 M(+18.8%) | -$104.09 M(-30.7%) |
| Jun 2024 | - | -$10.92 M(-61.7%) | -$150.30 M(-33.1%) |
| Mar 2024 | - | -$28.49 M(-44.9%) | -$224.77 M(-17.2%) |
| Dec 2023 | -$271.33 M(-7.5%) | -$51.70 M(-12.6%) | -$271.34 M(-4.7%) |
| Sep 2023 | - | -$59.19 M(-30.7%) | -$284.87 M(-10.3%) |
| Jun 2023 | - | -$85.40 M(+13.8%) | -$317.54 M(+4.1%) |
| Mar 2023 | - | -$75.06 M(+15.1%) | -$305.17 M(+4.1%) |
| Dec 2022 | -$293.43 M(+1.7%) | -$65.23 M(-29.0%) | -$293.11 M(-19.3%) |
| Sep 2022 | - | -$91.86 M(+25.8%) | -$363.12 M(+64.8%) |
| Jun 2022 | - | -$73.03 M(+15.9%) | -$220.28 M(-21.6%) |
| Mar 2022 | - | -$62.99 M(-53.4%) | -$281.10 M(-2.6%) |
| Dec 2021 | -$288.53 M(+54.9%) | -$135.24 M(-365.3%) | -$288.53 M(+36.7%) |
| Sep 2021 | - | $50.97 M(-138.1%) | -$211.03 M(-7.5%) |
| Jun 2021 | - | -$133.84 M(+90.0%) | -$228.19 M(+27.6%) |
| Mar 2021 | - | -$70.43 M(+22.0%) | -$178.84 M(-4.0%) |
| Dec 2020 | -$186.33 M(+152.6%) | -$57.74 M(-270.8%) | -$186.33 M(-17.5%) |
| Sep 2020 | - | $33.81 M(-140.0%) | -$225.97 M(-26.7%) |
| Jun 2020 | - | -$84.49 M(+8.5%) | -$308.45 M(+188.2%) |
| Mar 2020 | - | -$77.91 M(-20.0%) | -$107.01 M(+45.1%) |
| Dec 2019 | -$73.77 M(-1.8%) | -$97.38 M(+100.1%) | -$73.77 M(-255.9%) |
| Sep 2019 | - | -$48.66 M(-141.6%) | $47.31 M(-15.9%) |
| Jun 2019 | - | $116.94 M(-361.8%) | $56.28 M(-169.3%) |
| Mar 2019 | - | -$44.67 M(-288.5%) | -$81.26 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$75.13 M(-32.2%) | $23.69 M(-159.7%) | -$75.13 M(-42.5%) |
| Sep 2018 | - | -$39.69 M(+92.7%) | -$130.75 M(+16.0%) |
| Jun 2018 | - | -$20.60 M(-46.5%) | -$112.69 M(-7.0%) |
| Mar 2018 | - | -$38.53 M(+20.6%) | -$121.20 M(+9.3%) |
| Dec 2017 | -$110.85 M(+133.8%) | -$31.93 M(+47.6%) | -$110.85 M(+4.2%) |
| Sep 2017 | - | -$21.63 M(-25.7%) | -$106.37 M(+0.4%) |
| Jun 2017 | - | -$29.11 M(+3.3%) | -$105.97 M(+111.0%) |
| Mar 2017 | - | -$28.18 M(+2.6%) | -$50.22 M(+5.9%) |
| Dec 2016 | -$47.41 M(-36.4%) | -$27.45 M(+29.3%) | -$47.41 M(-30.6%) |
| Sep 2016 | - | -$21.24 M(-179.7%) | -$68.30 M(-23.6%) |
| Jun 2016 | - | $26.64 M(-205.0%) | -$89.37 M(+59.6%) |
| Mar 2016 | - | -$25.37 M(-47.5%) | -$55.99 M(-24.8%) |
| Dec 2015 | -$74.50 M(+53.9%) | -$48.33 M(+14.2%) | -$74.50 M(+1.0%) |
| Sep 2015 | - | -$42.31 M(-170.5%) | -$73.80 M(+8.1%) |
| Jun 2015 | - | $60.02 M(-236.8%) | -$68.30 M(-13.3%) |
| Mar 2015 | - | -$43.88 M(-7.9%) | -$78.76 M(+62.7%) |
| Dec 2014 | -$48.40 M(+1041.1%) | -$47.63 M(+29.4%) | -$48.40 M(+94.8%) |
| Sep 2014 | - | -$36.81 M(-174.3%) | -$24.84 M(-146.0%) |
| Jun 2014 | - | $49.56 M(-466.7%) | $53.97 M(+1123.5%) |
| Mar 2014 | - | -$13.51 M(-43.9%) | $4.41 M(-75.4%) |
| Dec 2013 | -$4.24 M(-81.3%) | -$24.07 M(-157.3%) | $17.93 M(-57.3%) |
| Sep 2013 | - | $41.99 M | $41.99 M |
| Dec 2012 | -$22.64 M | - | - |
FAQ
- What is FibroGen annual earnings before interest & taxes?
- What is the all time high annual EBIT for FibroGen?
- What is FibroGen annual EBIT year-on-year change?
- What is FibroGen quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for FibroGen?
- What is FibroGen quarterly EBIT year-on-year change?
- What is FibroGen TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for FibroGen?
- What is FibroGen TTM EBIT year-on-year change?
What is FibroGen annual earnings before interest & taxes?
The current annual EBIT of FGEN is -$271.33 M
What is the all time high annual EBIT for FibroGen?
FibroGen all-time high annual earnings before interest & taxes is -$4.24 M
What is FibroGen annual EBIT year-on-year change?
Over the past year, FGEN annual earnings before interest & taxes has changed by +$22.09 M (+7.53%)
What is FibroGen quarterly earnings before interest & taxes?
The current quarterly EBIT of FGEN is -$12.98 M
What is the all time high quarterly EBIT for FibroGen?
FibroGen all-time high quarterly earnings before interest & taxes is $116.94 M
What is FibroGen quarterly EBIT year-on-year change?
Over the past year, FGEN quarterly earnings before interest & taxes has changed by +$38.72 M (+74.90%)
What is FibroGen TTM earnings before interest & taxes?
The current TTM EBIT of FGEN is -$104.09 M
What is the all time high TTM EBIT for FibroGen?
FibroGen all-time high TTM earnings before interest & taxes is $56.28 M
What is FibroGen TTM EBIT year-on-year change?
Over the past year, FGEN TTM earnings before interest & taxes has changed by +$167.25 M (+61.64%)